GUIDED THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
GUIDED THERAPEUTICS, INC. (GTHP) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 4.83 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2026-05-15
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2026-03-31 was 4.83M shares.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2023-12-31 was 2.01M shares, a 1280.32% increase year-over-year.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2023-09-30 was 0.00 shares.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2023-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2023 was 2.98M shares, a 3.15% decline from fiscal 2022.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2022 was 3.08M shares, a 40.40% increase from fiscal 2021.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2021 was 2.19M shares.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2020 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|---|
| 2026-03-31 | 4.83M shares 10-Q · filed 2026-05-15 | |||
| 2023-12-31 | 2.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 2.01M shares derived: sum of 2 quarters · filed 2025-03-31 | 2.01M shares derived: sum of 3 quarters · filed 2025-03-31 | 2.98M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 973.75K shares 10-Q · filed 2024-11-14 | 1.12M shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 973.75K shares 10-Q · filed 2024-08-14 | 1.12M shares derived: sum of 3 quarters · filed 2024-08-14 | 1.12M shares derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | 973.75K shares 10-Q · filed 2024-05-14 | 1.12M shares derived: sum of 2 quarters · filed 2024-05-14 | 1.12M shares derived: sum of 3 quarters · filed 2024-05-14 | 1.77M shares derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 145.54K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 145.54K shares derived: sum of 2 quarters · filed 2024-03-28 | 795.54K shares derived: sum of 3 quarters · filed 2024-03-28 | 3.08M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 650.00K shares derived: sum of 2 quarters · filed 2022-11-14 | 2.93M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 650.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 2.93M shares 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | 2.28M shares 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | 2.19M shares 10-K · filed 2023-03-30 | |||
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-18 | 0.00 shares 10-Q · filed 2021-08-18 | 0.00 shares derived: sum of 3 quarters · filed 2021-08-18 | 0.00 shares derived: sum of 4 quarters · filed 2021-08-18 |
| 2021-03-31 | 0.00 shares 10-Q/A · filed 2021-08-18 | 0.00 shares derived: sum of 2 quarters · filed 2021-08-18 | 0.00 shares derived: sum of 3 quarters · filed 2021-08-18 | 0.00 shares derived: sum of 4 quarters · filed 2021-08-18 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-04-07 | 0.00 shares derived: sum of 2 quarters · filed 2021-04-07 | 0.00 shares derived: sum of 3 quarters · filed 2021-04-07 | 0.00 shares 10-K · filed 2021-04-07 |
| 2020-09-30 | 0.00 shares derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-05 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-05 | 0.00 shares 10-Q/A · filed 2020-11-05 | |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-20 | 0.00 shares 10-Q · filed 2020-08-20 | ||
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-07-07 |